
Vistin Pharma Investor Relations Material
Latest events

Q1 2025
Vistin Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vistin Pharma
Access all reports
Vistin Pharma AS is a global pharmaceutical company that produces and markets active pharmaceutical ingredients. The company offers its products to an extensive network of third party manufacturers. In addition, the company develops its own formulations that are produced and marketed by the Vistin Pharma AS subsidiary. As well as producing bulk APIs, Vistin Pharma has a wide range of products in different stages of development that it expects will be launched in 2016.
Vistin Pharma has experienced continued growth in demand for its products, both due to the expansion of the pharma industry and from the increasing amount of specialised niche pharmaceuticals being developed. Its focus is on supplying products for diabetes and autoimmunity therapies as well as antibiotics. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Key slides for Vistin Pharma


Q1 2025
Vistin Pharma


Q1 2025
Vistin Pharma
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
VISTN
Country
🇳🇴 Norway